Clinical implications of the "Multicenter Automatic Defibrillator Implantation Trial" (MADIT)

Area of Science:

• Cardiology
• Electrophysiology
• Preventive Medicine

Background:

• Chronic coronary patients face a high risk of sudden arrhythmic death, posing a significant therapeutic challenge.
• Conventional pharmaceutical treatments, including amiodarone, have limited efficacy in preventing sudden cardiac events in this population.

Purpose of the Study:

• To evaluate the efficacy of implantable defibrillators (ICDs) compared to conventional therapy for chronic coronary patients at high risk of sudden arrhythmic death.
• To define patient selection criteria for prophylactic ICD implantation based on established risk factors.

Main Methods:

• Prospective, randomized trial design.
• Comparison of survival rates between patients treated with ICDs and those receiving conventional pharmaceutical therapy.
• Identification of patients based on criteria including previous myocardial infarction and ejection fraction ≤ 0.35, and non-sustained ventricular tachycardia.

Main Results:

• Patients treated with ICDs demonstrated a 54% improvement in survival rates compared to conventional therapy (p < or = 0.009).
• The study identified specific risk profiles, including ejection fraction ≤ 0.35 and non-sustained ventricular tachycardia post-myocardial infarction, indicating suitability for ICDs.

Conclusions:

• Implantable defibrillators (ICDs) represent a highly efficacious therapy for chronic coronary patients at high risk of sudden arrhythmic death.
• Prophylactic ICD implantation should be strongly considered for patients with a history of myocardial infarction meeting the MADIT risk criteria.